ARCHIVES

ACS Challenged To Clarify Position On FDA Reform

This article is from The Cancer Letter archive.

Vol. 22 No. 09 | March 1, 1996

Download PDF Visit The Full Archive

Related Articles

Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival

September 28, 2012

In Brief: Geza Jak Reportedly Picked For Cancer Panel; Supreme Court To Hear Cigarette Label Case

April 12, 1991

NCI Cancer Education Program To Open To Innovative Ideas

April 2, 1993

Garb’s Questions, Answers About Cancer Program

December 5, 1980

Congress Signals Willingness to Break With Administration on NIH Funding.

March 24, 2006

Gleevec To Prevent Recurrence Of Gastrointestinal Cancer

December 26, 2008